Kurt J. Hilzinger

Kurt J. Hilzinger is a declared insider at 3 companies (board member); the most frequent names are Outlook Therapeutics, Inc., Cencora, Inc. and Humana Inc. In total, 47 filings cover trades dated from 8 February 2006 to 5 October 2022.

On the open market, the record shows 36 purchases worth €672k and 1 sale worth €4.8M. The net balance comes to €4.1M on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 4 share grants and 4 option exercises. 2022 to date brings 10 purchases and no sales.

The median purchase comes to €3,890. Clusters matter here: 26 out of 36 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.

Most recently, on 5 October 2022, the filings show an open-market purchase worth €19k in Outlook Therapeutics, Inc. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.